Film dosage form with extended release mucoadhesive particles

An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage...

Full description

Saved in:
Bibliographic Details
Main Authors Paiement, Nadine, Gonzalez-Labrada, Erick, Obeid, Rodolphe
Format Patent
LanguageEnglish
Published 16.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.
Bibliography:Application Number: US202117346874